111 related articles for article (PubMed ID: 10910272)
1. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model.
Nikolova Z; Hof A; Rudin M; Baumlin Y; Kraus G; Hof RP
Transplantation; 2000 Jun; 69(12):2525-30. PubMed ID: 10910272
[TBL] [Abstract][Full Text] [Related]
2. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
3. Allo- and autotransplantation of carotid artery--a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology.
Wehr S; Rudin M; Joergensen J; Hof A; Hof RP
Transplantation; 1997 Jul; 64(1):20-7. PubMed ID: 9233695
[TBL] [Abstract][Full Text] [Related]
4. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
[TBL] [Abstract][Full Text] [Related]
5. Neointima suppression in rat carotid allografts by FTY720 combined with a small fixed cyclosporine dose is related to a diminution of the peripheral lymphocyte count.
Nikolova Z; Hof RP
Transplant Proc; 2001 May; 33(3):2184-5. PubMed ID: 11377496
[No Abstract] [Full Text] [Related]
6. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
7. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
8. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
10. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
[TBL] [Abstract][Full Text] [Related]
11. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
13. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
[TBL] [Abstract][Full Text] [Related]
15. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation.
Mitsusada M; Suzuki S; Kobayashi E; Enosawa S; Kakefuda T; Miyata M
Transpl Int; 1997; 10(5):343-9. PubMed ID: 9287398
[TBL] [Abstract][Full Text] [Related]
16. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Wang D; Huang Y
Mol Vis; 2012; 18():624-33. PubMed ID: 22509094
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model.
Matsumoto Y; Hof A; Baumlin Y; Hof RP
Transplantation; 2002 Nov; 74(10):1372-6. PubMed ID: 12451233
[TBL] [Abstract][Full Text] [Related]
18. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.
Park SI; Felipe CR; Machado PG; Garcia R; Skerjanec A; Schmouder R; Tedesco-Silva H; Medina-Pestana JO
Braz J Med Biol Res; 2005 May; 38(5):683-94. PubMed ID: 15917949
[TBL] [Abstract][Full Text] [Related]
20. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
Mulgaonkar S; Tedesco H; Oppenheimer F; Walker R; Kunzendorf U; Russ G; Knoflach A; Patel Y; Ferguson R;
Am J Transplant; 2006 Aug; 6(8):1848-57. PubMed ID: 16771816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
